Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA methylation in thoracic neoplasms.

Chen Chen1, Ni Yin, Bangliang Yin

  • 1Department of Cardiothoracic Surgery, Second Xiangya Hospital of Central South University, Changsha, Hunan, PR China.

Cancer Letters
|November 20, 2010
PubMed
Summary

Aberrant DNA methylation patterns are crucial in thoracic tumor development. Inhibiting DNA methyltransferases (DNMTs) shows promise for novel anti-cancer therapies.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
Epigenetic Regulation01:46

Epigenetic Regulation

33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy.

Genes & diseases·2023
Same author

Microduplication of 7q36.3 encompassing the SHH long‑range regulator (ZRS) in a patient with triphalangeal thumb‑polysyndactyly syndrome and congenital heart disease.

Molecular medicine reports·2016
Same author

Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma.

Oncotarget·2015
Same author

Surgical management of a giant sternal chondromyxoid fibroma: a case report.

Journal of cardiothoracic surgery·2015
Same author

Regulation of Mcl-1 by constitutive activation of NF-κB contributes to cell viability in human esophageal squamous cell carcinoma cells.

BMC cancer·2014
Same author

MicroRNA-210 promotes proliferation and invasion of peripheral nerve sheath tumor cells targeting EFNA3.

Oncology research·2014

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Thoracic neoplasms, including lung, esophageal, and thymic tumors, are leading causes of cancer death globally.
  • Neoplasm development involves complex genetic and epigenetic changes.
  • Aberrant DNA methylation, such as promoter hypermethylation and global hypomethylation, is implicated in tumorigenesis.

Purpose of the Study:

  • To review methylation pattern disruptions in thoracic tumors.
  • To discuss the role of these abnormalities in cancer development.
  • To explore the therapeutic potential of DNA methyltransferase (DNMT) inhibition.

Main Methods:

  • Literature review of published observations on methylation patterns in thoracic neoplasms.
  • Analysis of studies investigating the role of DNA methylation in tumorigenesis.
  • Examination of research on DNMT activity and its impact on cancer.

Main Results:

  • Disrupted DNA methylation patterns are frequently observed in thoracic tumors.
  • These epigenetic alterations contribute significantly to the initiation and progression of thoracic cancers.
  • Inhibition of DNMTs demonstrates potent anti-cancer effects in preclinical studies.

Conclusions:

  • Aberrant DNA methylation is a key driver in thoracic neoplasm development.
  • Targeting DNMTs represents a promising strategy for developing novel therapeutic interventions for thoracic tumors.

Related Experiment Videos